{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:03:59Z","timestamp":1783652639822,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","award":["400000151"],"award-info":[{"award-number":["400000151"]}],"id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103188","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:12:03Z","timestamp":1623330723000},"page":"103188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients"],"prefix":"10.1016","volume":"60","author":[{"given":"Mahla","family":"Sattarzadeh Bardsiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4996-1748","authenticated-orcid":false,"given":"Seyedeh Mehrnaz","family":"Kouhbananinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Soleimany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Moghadari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Derakhshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4704-5276","authenticated-orcid":false,"given":"Bahareh","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Farsinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103188_bib0005","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","volume":"117","author":"Duan","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.transci.2021.103188_bib0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.transci.2021.103188_bib0015","series-title":"Coronavirus disease (COVID-19) pandemic","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.transci.2021.103188_bib0020","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI138745","article-title":"Deployment of convalescent plasma for the prevention and treatment of COVID-19","volume":"130","author":"Bloch","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.transci.2021.103188_bib0025","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/vox.12926","article-title":"Collecting and evaluating convalescent plasma for COVID\u201019 treatment: why and how?","volume":"115","author":"Tiberghien","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2021.103188_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.transci.2021.103188_bib0035","series-title":"FDA issues emergency use authorization for convalescent plasma as potential promising COVID\u201319 treatment, another achievement in administration\u2019s fight against pandemic","year":"2020"},{"key":"10.1016\/j.transci.2021.103188_bib0040","doi-asserted-by":"crossref","first-page":"001","DOI":"10.29328\/journal.icci.1001012","article-title":"Convalescent plasma: a valid option in the treatment of COVID-19","volume":"4","author":"Liu","year":"2020","journal-title":"Insights Clin Cell Immunol"},{"key":"10.1016\/j.transci.2021.103188_bib0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/vox.12927","article-title":"Pivotal role of convalescent plasma in managing emerging infectious diseases","volume":"115","author":"Wong","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.transci.2021.103188_bib0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.transci.2021.103188_bib0055","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/trf.13527","article-title":"Are there any alternatives for transfusion of AB plasma as universal donor in an emergency release setting?","volume":"56","author":"Balvers","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2021.103188_bib0060","series-title":"AABB technical manual","first-page":"778","article-title":"Methods section 4, cold agglutinin titer","year":"2005"},{"key":"10.1016\/j.transci.2021.103188_bib0065","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmhg.2015.07.004","article-title":"Distribution of ABO blood groups and rhesus factor in a Large Scale Study of different cities and ethnicities in Khuzestan province, Iran","volume":"17","author":"Paridar","year":"2016","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/j.transci.2021.103188_bib0070","series-title":"AABB technical manual","first-page":"768","article-title":"Antibody detection, antibody identification, and serologic compatibility testing","year":"2005"},{"key":"10.1016\/j.transci.2021.103188_bib0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1590\/1519-6984.21312","article-title":"Proposed method for agglutinating antibody titer analysis and its use as indicator of acquired immunity in pacu, Piaractus mesopotamicus","volume":"74","author":"Biller-Takahashi","year":"2014","journal-title":"Braz J Biol"},{"key":"10.1016\/j.transci.2021.103188_bib0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4067\/S0301-732X2010000300015","article-title":"Hematology and agglutination titer after polyvalent immunization and subsequent challenge with Aeromonas hydrophila in Nile tilapia (Oreochromis niloticus)","volume":"42","author":"Bailone","year":"2010","journal-title":"Arch Med Vet"},{"key":"10.1016\/j.transci.2021.103188_bib0085","first-page":"5","article-title":"Novel coronavirus (COVID-19): a new emerging pandemic threat","volume":"8","author":"Rezabakhsh","year":"2020","journal-title":"JRCM"},{"key":"10.1016\/j.transci.2021.103188_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/S2665-9913(20)30120-X","article-title":"The immunology of COVID-19: is immune modulation an option for treatment?","author":"Zhong","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.transci.2021.103188_bib0095","first-page":"1","article-title":"Mesenchymal stem cell therapy for COVID-19: present or future","author":"Golchin","year":"2020","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.transci.2021.103188_bib0100","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-020-1088-9","article-title":"Convalescent plasma treatment of severe COVID-19: a propensity score\u2013matched control study","volume":"26","author":"Liu","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.transci.2021.103188_bib0105","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2021.103188_bib0110","article-title":"Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients","author":"Wang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2021.103188_bib0115","doi-asserted-by":"crossref","DOI":"10.18502\/ijaai.v19i(s1.r1).2847","article-title":"Management of COVID-19 virus infection by convalescent plasma","author":"Cheraghali","year":"2020","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.transci.2021.103188_bib0120","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25961","article-title":"Convalescent plasma transfusion for the treatment of COVID\u201019: systematic review","author":"Rajendran","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.transci.2021.103188_bib0125","first-page":"35","article-title":"Use of convalescent plasma therapy in two COVID-19 patients with acute respiratory distress syndrome in Korea","author":"Ahn","year":"2020","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.transci.2021.103188_bib0130","series-title":"EUA of COVID-19 convalescent plasma for the treatment of COVID-19 in hospitalized patients: fact sheet for health care providers","author":"Food and Drug Administration","year":"2020"},{"key":"10.1016\/j.transci.2021.103188_bib0135","first-page":"300","article-title":"Utility of adsorption techniques in serological evaluation of warm autoimmune haemolytic anaemia","volume":"7","author":"Das","year":"2009","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2021.103188_bib0140","first-page":"227","article-title":"Factors affecting the antigen-antibody reaction","volume":"5","author":"Reverberi","year":"2007","journal-title":"Blood Transfus"},{"key":"10.1016\/j.transci.2021.103188_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00590","article-title":"New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia","volume":"11","author":"Berentsen","year":"2020","journal-title":"Front Immunol"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:14Z","timestamp":1761468734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221001610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221001610"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103188","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103188"}}